247 related articles for article (PubMed ID: 30778199)
1. HN1L-mediated transcriptional axis AP-2γ/METTL13/TCF3-ZEB1 drives tumor growth and metastasis in hepatocellular carcinoma.
Li L; Zheng YL; Jiang C; Fang S; Zeng TT; Zhu YH; Li Y; Xie D; Guan XY
Cell Death Differ; 2019 Nov; 26(11):2268-2283. PubMed ID: 30778199
[TBL] [Abstract][Full Text] [Related]
2. ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM.
Zhou Y; Lin F; Wan T; Chen A; Wang H; Jiang B; Zhao W; Liao S; Wang S; Li G; Xu Z; Wang J; Zhang J; Ma H; Lin D; Li Q
Theranostics; 2021; 11(12):5926-5938. PubMed ID: 33897890
[TBL] [Abstract][Full Text] [Related]
3. LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1 signaling pathway.
Li SP; Xu HX; Yu Y; He JD; Wang Z; Xu YJ; Wang CY; Zhang HM; Zhang RX; Zhang JJ; Yao Z; Shen ZY
Oncotarget; 2016 Jul; 7(27):42431-42446. PubMed ID: 27285757
[TBL] [Abstract][Full Text] [Related]
4. lncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1.
He C; Liu Z; Jin L; Zhang F; Peng X; Xiao Y; Wang X; Lyu Q; Cai X
Cell Physiol Biochem; 2018; 48(5):1928-1941. PubMed ID: 30092578
[TBL] [Abstract][Full Text] [Related]
5. GINS1 promotes ZEB1-mediated epithelial-mesenchymal transition and tumor metastasis via β-catenin signaling in hepatocellular carcinoma.
Liang J; Yao N; Deng B; Li J; Jiang Y; Liu T; Hu Y; Cao M; Hong J
J Cell Physiol; 2024 May; 239(5):e31237. PubMed ID: 38468464
[TBL] [Abstract][Full Text] [Related]
6. FOXO1 inhibits the invasion and metastasis of hepatocellular carcinoma by reversing ZEB2-induced epithelial-mesenchymal transition.
Dong T; Zhang Y; Chen Y; Liu P; An T; Zhang J; Yang H; Zhu W; Yang X
Oncotarget; 2017 Jan; 8(1):1703-1713. PubMed ID: 27924058
[TBL] [Abstract][Full Text] [Related]
7. SRXN1 stimulates hepatocellular carcinoma tumorigenesis and metastasis through modulating ROS/p65/BTG2 signalling.
Lv X; Yu H; Zhang Q; Huang Q; Hong X; Yu T; Lan H; Mei C; Zhang W; Luo H; Pang P; Shan H
J Cell Mol Med; 2020 Sep; 24(18):10714-10729. PubMed ID: 32746503
[TBL] [Abstract][Full Text] [Related]
8. YB1 regulates miR-205/200b-ZEB1 axis by inhibiting microRNA maturation in hepatocellular carcinoma.
Liu X; Chen D; Chen H; Wang W; Liu Y; Wang Y; Duan C; Ning Z; Guo X; Otkur W; Liu J; Qi H; Liu X; Lin A; Xia T; Liu HX; Piao HL
Cancer Commun (Lond); 2021 Jul; 41(7):576-595. PubMed ID: 34110104
[TBL] [Abstract][Full Text] [Related]
9. ZEB1 promotes tumorigenesis and metastasis in hepatocellular carcinoma by regulating the expression of vimentin.
Qin Y; Yu J; Zhang M; Qin F; Lan X
Mol Med Rep; 2019 Mar; 19(3):2297-2306. PubMed ID: 30664206
[TBL] [Abstract][Full Text] [Related]
10. HOXD9 promotes epithelial-mesenchymal transition and cancer metastasis by ZEB1 regulation in hepatocellular carcinoma.
Lv X; Li L; Lv L; Qu X; Jin S; Li K; Deng X; Cheng L; He H; Dong L
J Exp Clin Cancer Res; 2015 Oct; 34():133. PubMed ID: 26514226
[TBL] [Abstract][Full Text] [Related]
11. ZEB1 serves an oncogenic role in the tumourigenesis of HCC by promoting cell proliferation, migration, and inhibiting apoptosis via Wnt/β-catenin signaling pathway.
Li LY; Yang JF; Rong F; Luo ZP; Hu S; Fang H; Wu Y; Yao R; Kong WH; Feng XW; Chen BJ; Li J; Xu T
Acta Pharmacol Sin; 2021 Oct; 42(10):1676-1689. PubMed ID: 33514855
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma.
Zhou YM; Cao L; Li B; Zhang RX; Sui CJ; Yin ZF; Yang JM
Ann Surg Oncol; 2012 May; 19(5):1700-6. PubMed ID: 21584833
[TBL] [Abstract][Full Text] [Related]
13. ABCA8 is regulated by miR-374b-5p and inhibits proliferation and metastasis of hepatocellular carcinoma through the ERK/ZEB1 pathway.
Cui Y; Liang S; Zhang S; Zhang C; Zhao Y; Wu D; Wang J; Song R; Wang J; Yin D; Liu Y; Pan S; Liu X; Wang Y; Han J; Meng F; Zhang B; Guo H; Lu Z; Liu L
J Exp Clin Cancer Res; 2020 May; 39(1):90. PubMed ID: 32430024
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of hematological and neurological expressed 1 (HN1) is associated with a poor prognosis of hepatocellular carcinoma and its knockdown inhibits cell growth and migration partly by down-regulation of c-Met.
Chen JJ; Sun X; Mao QQ; Jiang XY; Zhao XG; Xu WJ; Zhong L
Kaohsiung J Med Sci; 2020 Mar; 36(3):196-205. PubMed ID: 31749294
[TBL] [Abstract][Full Text] [Related]
15. SENP1 regulates hepatocyte growth factor-induced migration and epithelial-mesenchymal transition of hepatocellular carcinoma.
Zhang W; Sun H; Shi X; Wang H; Cui C; Xiao F; Wu C; Guo X; Wang L
Tumour Biol; 2016 Jun; 37(6):7741-8. PubMed ID: 26695141
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of SNHG6 regulates ZEB1 expression by competitively binding miR-101-3p and interacting with UPF1 in hepatocellular carcinoma.
Chang L; Yuan Y; Li C; Guo T; Qi H; Xiao Y; Dong X; Liu Z; Liu Q
Cancer Lett; 2016 Dec; 383(2):183-194. PubMed ID: 27702662
[TBL] [Abstract][Full Text] [Related]
17. MYC associated zinc finger protein promotes the invasion and metastasis of hepatocellular carcinoma by inducing epithelial mesenchymal transition.
Luo W; Zhu X; Liu W; Ren Y; Bei C; Qin L; Miao X; Tang F; Tang G; Tan S
Oncotarget; 2016 Dec; 7(52):86420-86432. PubMed ID: 27861158
[TBL] [Abstract][Full Text] [Related]
18. METTL13 promotes nasopharyngeal carcinoma progression through regulating the ZEB1/TPT1 axis.
Ni H; Liang C; Zhou Z; Jiang B; Li Y; Shang H; Yu X
J Gene Med; 2023 May; 25(5):e3476. PubMed ID: 36735630
[TBL] [Abstract][Full Text] [Related]
19. Fucoidan-induced ID-1 suppression inhibits the in vitro and in vivo invasion of hepatocellular carcinoma cells.
Cho Y; Cho EJ; Lee JH; Yu SJ; Kim YJ; Kim CY; Yoon JH
Biomed Pharmacother; 2016 Oct; 83():607-616. PubMed ID: 27459117
[TBL] [Abstract][Full Text] [Related]
20. IGFBP2 upregulates ZEB1 expression and promotes hepatocellular carcinoma progression through NF-κB signaling pathway.
Guo Q; Yu DY; Yang ZF; Liu DY; Cao HQ; Liao XW
Dig Liver Dis; 2020 May; 52(5):573-581. PubMed ID: 31818638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
